ACE2 and COVID-19: It has also been speculated that—in addition to a stressed immune system and poor general health status of cancer patients—presence of a large number of ACE2-expressing cancer cells might facilitate virus replication and contribute to the high COVID-19 mortality of cancer patients [15,16,17].